Page last updated: 2024-08-16

gatifloxacin and amoxicillin-potassium clavulanate combination

gatifloxacin has been researched along with amoxicillin-potassium clavulanate combination in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (85.71)	29.6817
2010's	1 (14.29)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bettis, RB; Li, NF; McAdoo, MA; Pierce, PF; Sher, LD; Turner, MA	1
Baldwin, R; Levine, JH; Lode, H; Maesen, FP; Schreurs, AJ; Solèr, M; van Noord, JA; Zehrer, M	1
Kleutgens, K; Lode, H; Loos, U; Magyar, P; Muir, JF	1
Arguedas, A; Echols, R; Hamed, KA; Pierce, P; Rodriguez, A; Sáez-Llorens, X; Yang, J	1
Arguedas, A; Biswas, D; Echols, R; Hamed, KA; Husseman, M; Pichichero, M; Pierce, P; Sher, L	1
Appelbaum, PC; Bozdogan, B; Choi, DR; Credito, K; Dewasse, B; Kosowska-Shick, K; Lin, G; McGhee, P; Pankuch, GA; Ryu, JM	1
Chang, KC; Lui, KJ	1

Trials

5 trial(s) available for gatifloxacin and amoxicillin-potassium clavulanate combination

Article	Year
A multicenter, randomized, investigator-blinded study of 5- and 10-day gatifloxacin versus 10-day amoxicillin/clavulanate in patients with acute bacterial sinusitis. Clinical therapeutics, 2002, Volume: 24, Issue:2 Topics: Adult; Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Maxillary Sinusitis; Middle Aged; Single-Blind Method	2002
Randomised double-blind comparison of oral gatifloxacin and co-amoxiclav for acute exacerbation of chronic Bronchitis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2003, Volume: 22, Issue:3 Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Bacteria; Bacterial Infections; Bronchitis, Chronic; Double-Blind Method; Drug Administration Schedule; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Partial Pressure; Treatment Outcome; Vital Capacity	2003
Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome	2004
Randomized, investigator-blinded, multicenter study of gatifloxacin versus amoxicillin/clavulanate treatment of recurrent and nonresponsive otitis media in children. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:4 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, Preschool; Female; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome	2005
Randomized, investigator-blinded, multicenter, comparative study of gatifloxacin versus amoxicillin/clavulanate in recurrent otitis media and acute otitis media treatment failure in children. The Pediatric infectious disease journal, 2005, Volume: 24, Issue:4 Topics: Acute Disease; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Child; Child, Preschool; Female; Fluoroquinolones; Gatifloxacin; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Otitis Media; Pneumococcal Infections; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Treatment Failure; Treatment Outcome	2005

Other Studies

2 other study(ies) available for gatifloxacin and amoxicillin-potassium clavulanate combination

Article	Year
Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae	2006
Notes on testing noninferiority in ordinal data under the parallel groups design. Journal of biopharmaceutical statistics, 2013, Volume: 23, Issue:6 Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Data Interpretation, Statistical; Fluoroquinolones; Gatifloxacin; Humans; Models, Statistical; Monte Carlo Method; Odds Ratio; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Sample Size; Treatment Outcome	2013

Article

Year

Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents.

Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Cefuroxime; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Genes, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Molecular Structure; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae

2006

Notes on testing noninferiority in ordinal data under the parallel groups design.

Journal of biopharmaceutical statistics, 2013, Volume: 23, Issue:6

Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Community-Acquired Infections; Data Interpretation, Statistical; Fluoroquinolones; Gatifloxacin; Humans; Models, Statistical; Monte Carlo Method; Odds Ratio; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Sample Size; Treatment Outcome

2013